April 21, 2010

Rheonix, Inc. Completes $12.6 Million Series A Financing

Ithaca, NY — April 21, 2010 — Rheonix, Inc. today announced the completion of a $12.6 million Series A financing to continue development of the Rheonix CARD™ (Chemistry And Reagent Device) system. This powerful, analytic platform for the lifescience industry vertically integrates all the functions of traditional molecular diagnostic instrumentation into a single system to achieve unprecedented raw sample preparation, molecular amplification and multiplex analysis. The Rheonix CARD system provides… Read More »
Rheonix receives FDA Emergency Use Authorization for Automated COVID-19 Test.
Learn More